The first field trial of a new typhoid vaccine that can be used in young children provides protection for 81.6 per cent of recipients, opening the door to better control of a disease that affects 11 million people each year and kills roughly 117,000.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted